• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MXC 2.44% 42.0¢

MGC PHARMACEUTICALS LTD - Charts / Financials

MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on... MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on developing and commercialising phytocannabinoid derived medicines. The Company’s product offering currently targets two widespread medical conditions – epilepsy and dementia. Based in Europe, MGC Pharma is working to meet the growing demand for affordable high-quality phytocannabinoid medicines globally.More

refresh Created with Sketch. REFRESH
Day
Open 41.0¢   Day High 42.0¢   Day Low 39.5¢
Daily Volume 47232
Bids   Sellers
Number Price Volume   Number Price Volume
1 39.5¢ 1373   1 42.0¢ 9366

Directors & Senior Management

Mrs. Rachel Kerr Joint Company Secretary
Mr. Brett Anthony Mitchell Executive Chairman of the Board
Mr. Roby Reuven Zomer Chief Executive Officer, Managing Director, Executive Director
Ms. Yifat Steuer Deputy Chief Executive Officer, Chief Operating Officer
Mr. Robert Clements Chief Commercial Officer
Mr. Rowan Harland Company Secretary
Mr. Layton Mills Non-Executive Director
Mr. Daniel Robinson Non-Executive Director

Data source: Refinitiv

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.